Quantamental Technologies’s Vertex Pharmaceuticals VRTX Stock Holding History

Quantamental Technologies’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,282	Closed	-$777K	–	508
2021 Q3	$777K	Buy	4,282 +2,261	+112%	+$441K	0.52%	58
2021 Q2	$407K	Buy	+2,021	New	+$423K	0.36%	103
2020 Q4	–	Sell	-4,169	Closed	-$1.13M	–	269
2020 Q3	$1.13M	Buy	4,169 +412	+11%	+$114K	0.84%	27
2020 Q2	$1.09M	Buy	3,757 +757	+25%	+$205K	0.73%	35
2020 Q1	$714K	Buy	3,000 +1,798	+150%	+$412K	1.67%	14
2019 Q4	$263K	Buy	1,202 +377	+46%	+$76.3K	0.14%	291
2019 Q3	$140K	Sell	825 -5,111	-86%	-$904K	0.05%	613
2019 Q2	$1.09M	Buy	5,936 +5,540	+1,399%	+$968K	0.4%	19
2019 Q1	$73K	Buy	396 +151	+62%	+$27.9K	0.03%	720
2018 Q4	$41K	Buy	+245	New	+$42.5K	0.02%	836

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Quantamental Technologies's VRTX Position: Q4 2021 in Review

Quantamental Technologies sold out of Vertex Pharmaceuticals (VRTX) in Q4 2021, closing a stake of 4,282 shares — an estimated $777K sold.

Quantamental Technologies first reported a position in VRTX in Q4 2018 and held it in 10 quarters. The position peaked at $1.13M in Q3 2020. 1,033 funds tracked by Wall St. Rank hold VRTX as of Q4 2021.

Quantamental Technologies reported no remaining Vertex Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Quantamental Technologies sold 4,282 Vertex Pharmaceuticals shares in Q4 2021, an estimated $777K.
Quantamental Technologies first reported a position in Vertex Pharmaceuticals in Q4 2018 and held it in 10 quarters.
Quantamental Technologies's Vertex Pharmaceuticals position peaked at $1.13M in Q3 2020.
1,033 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2021.

Based on Quantamental Technologies's 13F filing for Q4 2021, filed 14 Feb 2022.